DÜNDAR, M. 2017. The Effect of CYP2C19*2 Polymorphism on Clopidogrel Resistance In COPD Patients. European Biotechnology Congress 2017 , (Dubrovnik, Croatia), 80.

DÜNDAR, M., (2017). The Effect of CYP2C19*2 Polymorphism on Clopidogrel Resistance In COPD Patients . European Biotechnology Congress 2017 (pp.80). Dubrovnik, Croatia

DÜNDAR, MUNİS. "The Effect of CYP2C19*2 Polymorphism on Clopidogrel Resistance In COPD Patients," European Biotechnology Congress 2017, Dubrovnik, Croatia, 2017

DÜNDAR, MUNİS. "The Effect of CYP2C19*2 Polymorphism on Clopidogrel Resistance In COPD Patients." European Biotechnology Congress 2017 , Dubrovnik, Croatia, pp.80, 2017

DÜNDAR, M. (2017) . "The Effect of CYP2C19*2 Polymorphism on Clopidogrel Resistance In COPD Patients." European Biotechnology Congress 2017 , Dubrovnik, Croatia, p.80.

@conferencepaper{conferencepaper, author={MUNİS DÜNDAR}, title={The Effect of CYP2C19*2 Polymorphism on Clopidogrel Resistance In COPD Patients}, congress name={European Biotechnology Congress 2017}, city={Dubrovnik}, country={Croatia}, year={2017}, pages={80} }